Genomma Lab Internacional SAB de CV (GNMLF)
Genomma Lab Internacional Market Cap: 1.032B for Jan. 7, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Corporativo Fragua SAB de CV | 2.840B |
| CEL-SCI Corp. | 17.66M |
| AIM ImmunoTech, Inc. | 1.009M |
| IGC Pharma, Inc. | 27.96M |
| NovaBay Pharmaceuticals, Inc. | 1.195B |
Market Cap Related Metrics
| PE Ratio | 11.57 |
| PS Ratio | 1.118 |
| Price to Book Value | 1.719 |
| Price to Free Cash Flow | 26.06 |
| Price | 1.06 |
| Earnings Yield | 8.64% |
| Operating PE Ratio | 5.273 |
| Normalized PE Ratio | 11.57 |